AstraZeneca's Crestor reduces risk of blood clots in the veins - A new analysis from the JUPITER study shows that CRESTOR® (rosuvastatin calcium) 20mg significantly cut the risk of venous …
Pharma News 5_16
There's a ton of stuff going on this week, plus we're in pre-ASCO mode (so lots of oncology news - scroll down for those headlines). Here we go: What's a vaptan? Maybe something pretty exciting - A …
Pharma News 11_30
Glaxo buying Reliant - GlaxoSmithKline Plc has agreed to buy privately held heart drug specialist Reliant Pharmaceuticals for $1.65 billion in cash, in a move to boost its flagging drug sales in the …